SynthesisInternational journal of clinical oncology2020

Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.

Keiichiro Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.